fluoxetine has been researched along with zimeldine in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (48.94) | 18.7374 |
| 1990's | 14 (29.79) | 18.2507 |
| 2000's | 5 (10.64) | 29.6817 |
| 2010's | 5 (10.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chen, HY; Lee, EH; Liang, KC; Lin, WR; Shiu, WH | 1 |
| Davies, LP | 1 |
| Waite, J | 1 |
| Baldwin, D; Fineberg, N; Green, M; Montgomery, D; Montgomery, SA; Shah, A | 1 |
| Rickels, K; Schweizer, E | 1 |
| Burkitt, P; Gabriel, R; Hawley, C; James, D; Montgomery, SA | 2 |
| DeNoble, VJ; Spencer, KR; Strek, KF | 1 |
| Fuller, RW | 1 |
| Joly, D; Sanger, DJ | 1 |
| Moyer, JA; Sigg, EB; Silver, PJ | 1 |
| Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A | 1 |
| Smith, DF | 1 |
| Rényi, L | 1 |
| Mendels, J | 1 |
| Awad, AG | 1 |
| Aronson, CE; Brunswick, DJ; Frazer, A; Kovachich, GB | 1 |
| Ostrow, D | 1 |
| Broadhurst, AM; Wood, MD; Wyllie, MG | 1 |
| Wernicke, JF | 1 |
| Dahms, JL; Seiden, LS; Shaughnessy, RA | 1 |
| Broadbent, J; Jones, RS | 1 |
| Gershon, S; Kelwala, S; Stanley, M | 1 |
| Feighner, JP | 1 |
| Harms, HH | 1 |
| Chouinard, G; Jones, B | 1 |
| Bymaster, FP; Reid, LR; Threlkeld, PG; Wong, DT | 1 |
| Klimek, V; Kordecka-Magiera, A; Maj, J; Mogilnicka, E | 1 |
| Abdul, M; Hoosein, NM; Logothetis, CJ | 1 |
| Hennies, HH; Reimann, W | 1 |
| Alhaider, AA; Mustafa, AA | 1 |
| Friedemann, MN; Gerhardt, GA; Hoffer, BJ; Luthman, J | 1 |
| Carlsson, A; Wong, DT | 1 |
| Chen, JX; Gershon, MD; Pan, H; Rothman, TP; Wade, PR | 1 |
| Chappell, RL; Schuette, E | 1 |
| Inazu, M; Kiuchi, Y; Kubota, N; Matsumiya, T; Oguchi, K; Takeda, H; Zhang, J | 1 |
| Esteban, S; García-Sevilla, JA; Lladó, J; Sastre-Coll, A | 1 |
| Izenwasser, S; Katz, JL; Terry, P | 1 |
| García-Colunga, J; López-Valdés, HE | 1 |
| Ikeda, K; Kobayashi, T; Washiyama, K | 1 |
8 review(s) available for fluoxetine and zimeldine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical overview of serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine | 1990 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
Therapeutic effects of serotonin uptake inhibitors in depression.
Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine | 1986 |
Clinical experience with serotonin reuptake inhibiting antidepressants.
Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine | 1987 |
The side effect profile and safety of fluoxetine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Clinical Trials as Topic; Drug Eruptions; Female; Fluoxetine; Humans; Influenza, Human; Lipidoses; Male; Middle Aged; Nausea; Nervous System Diseases; Patient Dropouts; Phospholipids; Placebos; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Initiation and Maintenance Disorders; Suicide, Attempted; Vision Disorders; Zimeldine | 1985 |
History of antidepressants: successes and failures.
Topics: Albuterol; Animals; Antidepressive Agents; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Dibenzocycloheptenes; Drug Evaluation, Preclinical; Fluoxetine; History, 20th Century; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Psychopharmacology; Receptors, Adrenergic; Receptors, Serotonin; Trazodone; Zimeldine | 1983 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Zimeldine | 1983 |
5 trial(s) available for fluoxetine and zimeldine
| Article | Year |
|---|---|
Clinical experience with serotonin reuptake inhibiting antidepressants.
Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine | 1987 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
The side effect profile and safety of fluoxetine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Clinical Trials as Topic; Drug Eruptions; Female; Fluoxetine; Humans; Influenza, Human; Lipidoses; Male; Middle Aged; Nausea; Nervous System Diseases; Patient Dropouts; Phospholipids; Placebos; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Initiation and Maintenance Disorders; Suicide, Attempted; Vision Disorders; Zimeldine | 1985 |
History of antidepressants: successes and failures.
Topics: Albuterol; Animals; Antidepressive Agents; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Dibenzocycloheptenes; Drug Evaluation, Preclinical; Fluoxetine; History, 20th Century; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Psychopharmacology; Receptors, Adrenergic; Receptors, Serotonin; Trazodone; Zimeldine | 1983 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Zimeldine | 1983 |
38 other study(ies) available for fluoxetine and zimeldine
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Fluoxetine and 8-OH-DPAT in the lateral septum enhances and impairs retention of an inhibitory avoidance response in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Avoidance Learning; Brain Mapping; Dose-Response Relationship, Drug; Fear; Fluoxetine; Injections; Ketanserin; Male; Mental Recall; Rats; Rats, Inbred Strains; Receptors, Serotonin; Retention, Psychology; Ritanserin; Septum Pellucidum; Tetrahydronaphthalenes; Zimeldine | 1992 |
Fluoxetine-induced lung damage.
Topics: Animals; Female; Fluoxetine; Humans; Lung Diseases; Middle Aged; Rats; Zimeldine | 1992 |
Safety of 5-HT reuptake inhibitors.
Topics: Depressive Disorder; Fluoxetine; Humans; Risk Factors; Serotonin Antagonists; Zimeldine | 1991 |
Plasma-level response relationships with fluoxetine and zimelidine.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Zimeldine | 1990 |
Hypersensitivity to zimelidine without cross reactivity to fluoxetine.
Topics: Adult; Depressive Disorder; Drug Hypersensitivity; Female; Fluoxetine; Humans; Middle Aged; Zimeldine | 1989 |
Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats.
Topics: Animals; Avoidance Learning; Cyproheptadine; Dose-Response Relationship, Drug; Fluoxetine; Hypoxia; Ketanserin; Male; Methysergide; Mianserin; Rats; Rats, Inbred Strains; Serotonin; Zimeldine | 1989 |
The specificity of the zimelidine reaction.
Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Hypersensitivity; Fluoxetine; Humans; Middle Aged; Polyradiculoneuropathy; Syndrome; Zimeldine | 1989 |
The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Fluoxetine; Male; Metergoline; Olfactory Bulb; Propylamines; Rats; Rats, Inbred Strains; Zimeldine | 1986 |
Antidepressants and protein kinases: desipramine treatment affects pineal gland cAMP-dependent protein kinase activity.
Topics: Animals; Antidepressive Agents; Desipramine; Fluoxetine; Iprindole; Isoproterenol; Male; Pineal Gland; Protein Kinases; Rats; Rats, Inbred Strains; Zimeldine | 1986 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
Topics: Alanine; Animals; Behavior, Animal; Citalopram; Ejaculation; Fluoxetine; Male; Metergoline; Methoxydimethyltryptamines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Time Factors; Zimeldine | 1986 |
New antidepressants--the serotonin reuptake inhibitors.
Topics: Brain; Depressive Disorder; Fluoxetine; Humans; Propylamines; Receptors, Serotonin; Trazodone; Zimeldine | 1987 |
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.
Topics: 1-Naphthylamine; Animals; Autoradiography; Binding, Competitive; Brain; Fluoxetine; Imipramine; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Zimeldine | 1988 |
Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
Topics: Animals; Carrier Proteins; Catecholamines; Cerebral Cortex; Energy Metabolism; Fluoxetine; Imipramine; In Vitro Techniques; Kinetics; Male; Piperidines; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, Neurotransmitter; Serotonin; Synaptosomes; Zimeldine | 1986 |
Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.
Topics: Animals; Antidepressive Agents; Bupropion; Clozapine; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Trazodone; Zimeldine | 1985 |
Differential effects of fluoxetine and zimelidine on the uptake of 5-hydroxytryptamine and tryptamine by cortical slices and on responses of cortical neurones to stimulation of the nucleus raphe medianus.
Topics: Animals; Brompheniramine; Cerebral Cortex; Electric Stimulation; Fluoxetine; Male; Neurons; Propylamines; Pyridines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Tryptamines; Zimeldine | 1982 |
The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue.
Topics: Absorption; Animals; Antidepressive Agents; Cerebral Cortex; Desipramine; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Male; Norepinephrine; Oximes; Rats; Serotonin; Zimeldine | 1983 |
No crossover of hypersensitivity between zimelidine and fluoxetine.
Topics: Adult; Cross Reactions; Drug Hypersensitivity; Female; Fluoxetine; Humans; Propylamines; Zimeldine | 1984 |
Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Brompheniramine; Cattle; Fluoxetine; Fluvoxamine; Male; Neurons; Oximes; Propylamines; Rats; Rats, Inbred Strains; Receptors, Histamine; Receptors, Neurotransmitter; Serotonin; Zimeldine | 1983 |
Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism.
Topics: Aggression; Amitriptyline; Animals; Antidepressive Agents; Brompheniramine; Clonidine; Drug Synergism; Fluoxetine; Humans; Male; Maprotiline; Mice; Zimeldine | 1981 |
Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines.
Topics: Animals; Carcinoma; Cell Division; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Quipazine; Selective Serotonin Reuptake Inhibitors; Soft Tissue Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured; Zimeldine | 1995 |
Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol.
Topics: Animals; Fluoxetine; In Vitro Techniques; Kinetics; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Spinal Cord; Stereoisomerism; Synaptosomes; Tramadol; Zimeldine | 1994 |
Differential effects of fluoxetine on isoprenaline-stimulated water intake in ethanol-treated rats: a role for beta-adrenoceptors.
Topics: Analysis of Variance; Animals; Desipramine; Drinking; Drug Interactions; Ethanol; Fluoxetine; Fluvoxamine; Injections, Intraperitoneal; Isoproterenol; Male; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Zimeldine | 1993 |
In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors.
Topics: Animals; Animals, Newborn; Biogenic Monoamines; Corpus Striatum; Electrochemistry; Fluoxetine; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptosomes; Zimeldine | 1997 |
Correction: a note on the discovery of selective serotonin reuptake inhibitors.
Topics: Belgium; Fluoxetine; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Zimeldine | 1997 |
Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception.
Topics: Amino Acid Sequence; Animals; Base Sequence; Biological Transport; Brain Stem; Carrier Proteins; Clomipramine; Cloning, Molecular; Desipramine; DNA, Complementary; Fluoxetine; Guinea Pigs; HeLa Cells; Humans; Imipramine; Intestinal Mucosa; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Nerve Tissue Proteins; Neurons; Peristalsis; Polymerase Chain Reaction; Rats; Recombinant Proteins; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Transcription, Genetic; Zimeldine | 1998 |
Excitatory amino acids and serotonin uptake blockers reveal two physiologically distinct serotonin systems in the retina of the skate, Raja erinacea.
Topics: Animals; Aspartic Acid; Excitatory Amino Acid Antagonists; Fluoxetine; Monoamine Oxidase Inhibitors; N-Methylaspartate; Organ Culture Techniques; Pargyline; Potassium; Retina; Selective Serotonin Reuptake Inhibitors; Serotonin; Skates, Fish; Zimeldine | 1998 |
Pharmacological characterization of dopamine transport in cultured rat astrocytes.
Topics: Animals; Astrocytes; Biological Transport, Active; Carrier Proteins; Cells, Cultured; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Kinetics; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Sodium; Symporters; Zimeldine | 1999 |
Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Topics: 5-Hydroxytryptophan; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Tricyclic; Autoreceptors; Brain; Carboxy-Lyases; Cerebral Cortex; Desipramine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Hippocampus; Male; Norepinephrine; Protriptyline; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors; Tryptophan; Tyrosine; Zimeldine | 1999 |
Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects.
Topics: Animals; Binding, Competitive; Carrier Proteins; Caudate Nucleus; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Membranes; Nerve Tissue Proteins; Psychomotor Performance; Putamen; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tritium; Zimeldine | 2000 |
Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.
Topics: Acetylcholine; Animals; Antidepressive Agents; Biogenic Monoamines; Female; Fluoxetine; Imipramine; Membrane Potentials; Muscle, Skeletal; Neurons; Neurotransmitter Uptake Inhibitors; Oocytes; Protein Subunits; Rats; Receptors, Nicotinic; Recombinant Proteins; Xenopus laevis; Zimeldine | 2001 |
Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).
Topics: Animals; Brain; Dose-Response Relationship, Drug; Ethanol; Female; Fluoxetine; Fluvoxamine; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart; Mice; Potassium Channels; Potassium Channels, Inwardly Rectifying; RNA, Messenger; Xenopus laevis; Zimeldine | 2003 |